Menu
Advanced search Subscribe
About

Home > About > Team > Katrina Erny-Albrec…

Dr Katrina Erny-Albrecht

BSc (Hons), PhD

Position

Senior Research Fellow

Contact details

Email:
Phone: 08 7221 8524

Brief biography

Prior to working with PHCRIS, Katrina worked in Switzerland as a health economics consultant/medical writer in the field of diabetes with IMS-Health Basel (formerly CORE GmbH), and as a Research Associate with the Institute for Medical Informatics and Biostatistics (IMIB), Basel. After returning to Australia late in 2011 she worked at the Flinders University School of Nursing and Midwifery on a project to develop online course materials for student learning in health sciences and pharmacology before joining PHCRIS in July 2013.

Peer-reviewed publications

  • TshiangaTshiananga JKT, Kocher, S, Weber C, Erny-Albrecht K, Berndt K, Neeser K. (2011). The effect of Nurse-led Diabetes Self-management on glycosylated Hemoglobin and Cardiovascular Risk Factors: A Meta-Analaysis. The DiabEduc, 37(6)
  • Pollock RF, Erny-Albrecht KM, Kalsekar A, Bruhn D, Valentine WJ. (2011). Long-acting insulin analogs: a review of “real-world” effectiveness in patients with type 2 diabetes. Curr Diabetes Rev, 7(1), 61-74
  • Brändle M, Goodall G, Erny-Albrecht KM, Erdmann, E, Valentine, W .(2009). Cost-effectiveness of pioglitazone in patients with type 2 diabetes and a history of macrovascular disease in a Swiss Setting. Swiss Medical Weekly, 139(11-12), 173-184
  • Scherbaum WA, Goodall G, Erny-Albrecht KM, Massi-Benedetti M,Erdmann E, Valentine J. (2009). Cost-effectiveness of pioglitazone in type 2 diabetes patients with a history of macrovascular disease: a German perspective. Cost EffResAlloc, 7, 9
  • Brändle M, Erny-Albrecht KM, Goodall G, Spinas GA, Streit P, Valentine WJ. (2009). Exenatide versus insulin glargine: a cost-effectiveenss evaluation in patients with Type 2 diabetes in Switzerland. Int J Clin Pharmacol Ther, 47(8), 501-515
  • Valentine WJ, Goodall G, Aagren M, Nielsen S, Palmer AJ, Erny-Albrecht KM. (2008). Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes. Adv Ther, 25(6), 567-84
  • Valentine WJ, Erny-Albrecht KM, Ray JA, Roze S, Cobden D, Palmer AJ. (2007). Therapy conversion to insulin detemir among patients with type 2 diabetes treated with oral agents: a modeling study of cost-effectiveness in the United States. Adv Therapy, 24(2), 273-290
  • Katrina Erny-Albrecht, William J. Valentine, Jens Christensen, Ulrik Vestenbaek, Andrew J Palmer. (2007). Sublingual immunotherapy in allergic rhinitis and asthma:a review of recent clinical evidence. J applied Research, 7(1), 17-31
  • Gilmer TP, Roze S, Valentine, WJ, Erny-Albrecht K, Ray JA, Cobden D, Nicklasson L, Philis-Tsimikas A, Palmer AJ. (2007). Cost-effectiveness of diabetes case management for low-income populations. Health Services Research, 42(5), 1943-59.
  • Valentine WJ, Palmer AJ, Erny-Albrecht KM, Ray JA, Cobden D, Foos V, Lurati FM, Roze S. (2006). Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine and NPH. AdvTher, 23(2), 191-207
  • Neeser K, Erny-Albrecht K, Weber C. (2006). Cost-effectiveness of self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin. Diabetes Care, 29(2), 480
  • Neeser K, Erny-Albrecht K, Völler H, Weber C. (2006). Antikoagulation mit oralen Vitamin-K-Antagonisten bei Risikopatienten: klinischer und wirtschaftlicher Nutzen einer adäquaten Prävention. J Kardiol, 13, 313-320
  • Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, Rauscher FJ, Thor AD, Benz CC. (2000). Ets regulation of the erbB2 promoter. Oncogene, 19(55), 6490-502
  • Chang C-H, Scott G, Kuo WL, Xiong X, Suzdaltseva Y, Park JW, Sayre P, Erny K, Collins C, Gray J, Benz C. (1997). ESX a structurally unique Ets over expressed early during human breast tumorigenesis. Oncogene, 14, 1617-1622
  • Maillard I, Erny KM, Acha-Orbea H, Diggelmann H. (1996). A Vb4 specific superantigen encoded by a new exogenous mouse mammary tumor virus. Eur.J. Immun., 26(5), 1000-1006
  • Erny KM, Peli J, Lamber J-F, Muller V, Diggelmann H. (1996). Involvement of the Tpl-2/cot oncogene in MMTV tumorogenesis. Oncogene, 13(9), 2015-2020
  • Erny KM, Sheppard M, Fahey KJ. (1995). Immunopathogenesis and physical maps of fowl adenovirus serotype 9. 1995 Res. Vet. Sci, 61(2), 174-175
  • Erny KM, Pallister JA, Sheppard M. (1995). Immunological and molecular comparison of fowl adenovirus serotypes 4 and 10. Archives Virol., 140, 491-501
  • Pallister JA, Erny KM, Fahey KJ. (1996). Serological relationships within the group E fowl adenoviruses. Intervirology, 36, 84-90
  • Erny KM, Sheppard M. (1996). Replication cycle and associated biosynthetic reactions for a non-oncogenic avian adenovirus. Virus Res., 29, 203-209
  • Erny KM, Barr DA, Fahey KJ. (1991). Molecular characterization of highly virulent fowl adenoviruses associated with outbreaks of inclusion body hepatitis. Avian Pathology, 20, 597-606
  • Fahey KJ, McWater P, Brown MA, Erny KM, Murphy VJ, Hewish D. (1991). Virus neutralizing and passively protective monoclonal antibodies to infectious bursal disease virus of chickens. Avian Diseases, 35, 365-373
  • Sheppard M, Erny KM. (1989). DNA sequence analysis of the inverted terminal repeats of a non-oncogenic avian adenovirus. Nucleic Acid Research, 17(10), 3995
  • Fahey KJ, Erny KM, Crooks J. (1989). A conformational immunogen on VP-2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J. Gen. Virol., 70, 1473-1481
  • Azad AA, Fahey KJ, Barrett SA, Erny KM, Hudson PJ. (1986). Expression in Escherichia coli of cDNA fragments encoding the gene of the host protective antigen of Infectious bursal disease virus. Virology, 149, 190-198

Links

Visit Katrina’s Research Profile for details of her research activities (including current projects, publications and PHC Research Conference abstract submissions).

Share this content

Share via Twitter Share via LinkedIn Share via Facebook Share via email